Diagnostic and therapeutic challenges of cutaneous leishmaniasis in Canada: A case report [0.03%]
加拿大皮肤利什曼病的诊断和治疗挑战：一例报告
Adam C Yu,Airiss R Chan,Alena Tse-Chang et al.
Adam C Yu et al.
Cutaneous leishmaniasis is increasingly reported in non-endemic areas due to international travel. This case describes a 17-year-old male from Western Canada who developed localized cutaneous leishmaniasis (Leishmania mexicana) after visiti...
Case report: The diagnostic dilemma created by non-infectious diffuse abdominal pain and hypereosinophilia in a teenage boy [0.03%]
病例报告：一名少年患者出现非感染性弥漫性腹痛和高嗜酸性粒细胞增多的诊断难题
Kylan A Nelson,Jamie Nong,Kevin Murray et al.
Kylan A Nelson et al.
When abdominal pain presents with peripheral eosinophilia, allergic and infectious causes should be considered. However, diagnostic dilemmas are frequent when symptoms do not match expected patterns of common etiologies. In this report, we ...
Management of sequential intraocular lens dislocations in a single eye following prior complicated cataract surgery: A case report [0.03%]
单眼复杂白内障手术后继发性人工晶状体连续脱位的管理：病例报告
Jacqueline Ying Liew,Pui Theng Yong,Angela Voon Pei Loo et al.
Jacqueline Ying Liew et al.
Dislocation of the intraocular lens after cataract surgery is uncommon but can cause a serious complication. We present a rare case of a patient with a dislocated posterior chamber intraocular lens and subluxated anterior chamber intraocula...
Refractory erythroderma in idiopathic hypereosinophilic syndrome: A case treated with mepolizumab and abrocitinib [0.03%]
特发性高嗜酸粒细胞综合征难治性红皮病一例：伊那利珠单抗和阿布昔替尼联合治疗体会
Hiba Elhaj,Ahmad Al Amari,Fatemah Alyaqout et al.
Hiba Elhaj et al.
Chronic erythroderma with persistent hypereosinophilia presents significant diagnostic and therapeutic challenges. We report the case of a 26-year-old man with a 6-year history of refractory erythroderma and eosinophilia. Extensive workup e...
Sophia Urban,Jackson Pearce,Nathalie Malcolm et al.
Sophia Urban et al.
Our case involves the clinical course of a healthy male infant who developed a calcified cephalohematoma despite no history of birth trauma or the use of assistive delivery instruments. Another unique feature of the patient's presentation w...
Phosphodiesterase-4 inhibition in localized scleroderma: A case series of topical roflumilast [0.03%]
局部硬皮病中磷二酯酶-4抑制剂的使用：罗氟司特外用治疗个例系列报告
Ghassan Barnawi,Alexandra Carla Bobica,Hessah BinJadeed et al.
Ghassan Barnawi et al.
Localized scleroderma, or morphea, is a chronic fibrosing skin condition with limited therapeutic options, particularly for patients who are elderly, immunocompromized, or intolerant to systemic immunosuppressants. We present three adult pa...
Dramatic clearance of extensive psoriasis in a pediatric patient treated with upadacitinib: A case report [0.03%]
乌帕替尼治疗儿童广泛银屑病的显著清除效果：病例报告
Jenna Mistry,Michal Moshkovich,Maxwell Sauder et al.
Jenna Mistry et al.
We present a unique case of an 8-year-old boy with severe, treatment-refractory palmoplantar psoriasis and genital involvement, unresponsive to nine systemic agents, including multiple biologics and TYK2 inhibition with deucravacitinib. Fol...
Case report: Causes of acute respiratory distress syndrome complications after lung resection [0.03%]
个例报告：肺切除术后急性呼吸窘迫综合征的并发症及原因分析
Liu Chang,Li Zhengjun,Zhang Yumeng et al.
Liu Chang et al.
Postoperative acute respiratory distress syndrome (ARDS), characterized by bilateral infiltrates and severe hypoxemia, is a critical complication following thoracic surgery, particularly lung resection. Perioperative transfusions and mechan...
Perforating dermatosis in a young female patient receiving adalimumab biosimilar CTP-17 for chronic plaque psoriasis: A case report [0.03%]
接受阿达木单抗类似药CTP-17治疗的年轻女性患者的慢性斑块型银屑病穿刺性皮炎1例报告
Alessia Lozito,Silvia Baravalle,Gabriele Poddine et al.
Alessia Lozito et al.
Adalimumab, a tumor necrosis factor-alpha inhibitor, is widely used for chronic plaque psoriasis and psoriatic arthritis. While cutaneous adverse effects are known, perforating dermatosis is rare and poorly understood. A 34-year-old woman w...
Paradoxical lichenoid drug eruption following dupilumab use for atopic dermatitis: A case report [0.03%]
达克珠单抗治疗特应性皮炎后出现药疹样_ly的矛盾反应一例报告
Maharshi Gandhi,Kaitlin Vanderbeck,Lyne Giroux
Maharshi Gandhi
Dupilumab is a monoclonal antibody targeting interleukin-4 (IL-4) and interleukin-13 (IL-13) signaling, approved for moderate-to-severe atopic dermatitis. Although generally well tolerated, paradoxical cutaneous reactions have been reported...